Shout out to APC board member Jim Hrncir of Irving, Texas — he was the guest on the podcast "The...
Scott goes deep on “Hims House” podcast
If you’re interested in a good, down-in-the-weeds podcast episode about … well, pretty much the entire compounding universe, check out episode 45 of the Hims House podcast, featuring APC CEO Scott Brunner, released this week.
They cover GLP-1 demand in the post-GLP-1–shortage landscape, pharma lawsuits, regulatory changes, and even some of the nitty-gritty like the demonstrably difficult to compound list, compounded hormone therapy, and peptides.
Oh, and there’s more — we did say it was about the entire compounding universe, didn’t we? Scott talks congressional actions, MAHA, drug patents, 503B production, FDA’s MOU with states (and the 5% rule), and how APC’s Blueprint ties into it all. A meaty episode, especially at only 45 minutes.
